|
Feb 25
|
J&J’s potential neurovascular exit: implications for market dynamics
|
|
Feb 14
|
Terumo Corp (TRUMF) Q3 2025 Earnings Call Highlights: Record Revenue and Strategic Growth Amid ...
|
|
Feb 5
|
Terumo Neuro Showcases Fully Integrated, Comprehensive Stroke Portfolio at International Stroke Conference Delivering Groundbreaking Innovation from Access to Revascularization
|